HCV routes of transmission: What goes around comes around

Seminars in Liver Disease

Volumn 31, Issue 4, 2011, Pages 340-346

  Alter, Miriam J ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

drug use; epidemiology; HCV; iatrogenic; sexual

Indexed keywords

COSMETIC; ILLICIT DRUG;

ARTICLE; BLOOD DONOR; BLOOD SAFETY; BLOOD TRANSFUSION; BODY PIERCING; HEPATITIS B VIRUS; HEPATITIS C; HOSPITAL INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFECTION CONTROL; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MALE HOMOSEXUAL; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; TATTOOING; UNITED STATES; UNSAFE SEX; VIRUS TRANSMISSION;

BLOOD TRANSFUSION; HEPACIVIRUS; HEPATITIS C; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HIV INFECTIONS; HUMANS; IATROGENIC DISEASE; RISK FACTORS; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES, VIRAL; STREET DRUGS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 84455209550     PISSN: 02728087     EISSN: 10988971     Source Type: Journal    
DOI: 10.1055/s-0031-1297923     Document Type: Article

References (68)

1. Feinstone S M., Kapikian A Z., Purcell R H., Alter H J., Holland P V. Transfusion-associated hepatitis not due to viral hepatitis type A or B. N Engl J Med 1975 292 15 767-770
2. Mosley J W., Redeker A G., Feinstone S M., Purcell R H. Mutliple hepatitis viruses in multiple attacks of acute viral hepatitis. N Engl J Med 1977 296 2 75-78 (Pubitemid 8017139)
3. Aach R D., Kahn R A. Post-transfusion hepatitis: current perspectives. Ann Intern Med 1980 92 4 539-546 (Pubitemid 10156702)
4. Tabor E, Snoy P, Gerety R J., Wickerhauser M, Menache D, Seeff L B. Transmission of agent of post-transfusion non-A, non-B hepatitis by cryoprecipitate prepared from plasma of symptomless chronic carrier. Lancet 1983 1 8314-5 63-64
5. Cossart Y E., Kirsch S, Ismay S L. Post-transfusion hepatitis in Australia. Report of the Australian Red Cross study. Lancet 1982 1 8265 208-213 (Pubitemid 12212906)
6. Grillner L, Bergdahl S, Jyrälä A. Non-A, non-B hepatitis after open-heart surgery in Sweden. Scand J Infect Dis 1982 14 3 171-175 (Pubitemid 12032717)
7. Meyers J D., Dienstag J L., Purcell R H., Thomas E D., Holmes K K. Parenterally transmitted non-A, non-B hepatitis: an epidemic reassessed. Ann Intern Med 1977 87 1 57-59 (Pubitemid 8144025)
8. Alter M J., Gerety R J., Smallwood L A. et al. Sporadic non-A, non-B hepatitis: frequency and epidemiology in an urban U.S. population. J Infect Dis 1982 145 6 886-893 (Pubitemid 12088968)
9. Alter M J., Coleman P J., Alexander W J. et al. Importance of heterosexual activity in the transmission of hepatitis B and non-A, non-B hepatitis. JAMA 1989 262 9 1201-1205 (Pubitemid 19206696)
10. Choo Q L., Weiner A J., Overby L R., Kuo G, Houghton M, Bradley D W. Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis. Br Med Bull 1990 46 2 423-441 (Pubitemid 20158079)
11. Alter H J., Purcell R H., Shih J W. et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989 321 22 1494-1500 (Pubitemid 20015539)
12. Kuo G, Choo Q L., Alter H J. et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989 244 4902 362-364 (Pubitemid 19117878)
13. Alter M J., Margolis H S., Krawczynski K et al. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med 1992 327 27 1899-1905 (Pubitemid 23006964)
14. Seeff L B., Buskell-Bales Z, Wright E C. et al. Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group. N Engl J Med 1992 327 27 1906-1911
15. Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Recomm Rep 1998 47 RR-19 1-39
16. Alter M J. Epidemiology of hepatitis C virus infection. World J Gastroenterol 2007 13 17 2436-2441 (Pubitemid 46929498)
17. Busch M P., Glynn S A., Stramer S L. et al, NHLBI-REDS NAT Study Group. A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion 2005 45 2 254-264 (Pubitemid 40180144)
18. Hladik W, Kataaha P, Mermin J et al. Prevalence and screening costs of hepatitis C virus among Ugandan blood donors. Trop Med Int Health 2006 11 6 951-954 (Pubitemid 43846456)
19. Hauri A M., Armstrong G L., Hutin Y J. The global burden of disease attributable to contaminated injections given in health care settings. Int J STD AIDS 2004 15 1 7-16 (Pubitemid 38096122)
20. Frank C, Mohamed M K., Strickland G T. et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 2000 355 9207 887-891 (Pubitemid 30137669)
21. Perz J F., Thompson N D., Schaefer M K., Patel P R. US outbreak investigations highlight the need for safe injection practices and basic infection control. Clin Liver Dis 2010 14 1 137-151, x
22. Alter M J. Healthcare should not be a vehicle for transmission of hepatitis C virus. J Hepatol 2008 48 1 2-4 (Pubitemid 350192001)
23. Centers for Disease Control and Prevention (CDC). Transmission of hepatitis B and C viruses in outpatient settingsNew York, Oklahoma, and Nebraska, 2000-2002. MMWR Morb Mortal Wkly Rep 2003 52 38 901-906
24. Desenclos J C., Bourdiol-Razäs M, Rolin B et al. Hepatitis C in a ward for cystic fibrosis and diabetic patients: possible transmission by spring-loaded finger-stick devices for self-monitoring of capillary blood glucose. Infect Control Hosp Epidemiol 2001 22 11 701-707 (Pubitemid 34132011)
25. Krause G, Trepka M J., Whisenhunt R S. et al. Nosocomial transmission of hepatitis C virus associated with the use of multidose saline vials. Infect Control Hosp Epidemiol 2003 24 2 122-127 (Pubitemid 36206080)
26. Germain J M., Carbonne A, Thiers V et al. Patient-to-patient transmission of hepatitis C virus through the use of multidose vials during general anesthesia. Infect Control Hosp Epidemiol 2005 26 9 789-792 (Pubitemid 41383129)
27. Thompson N D., Perz J F., Moorman A C., Holmberg S D. Nonhospital health care-associated hepatitis B and C virus transmission: United States, 1998-2008. Ann Intern Med 2009 150 1 33-39
28. Phillips L D. History of I.V. therapy. In: Davis F A. ed. Manual of I.V. Therapeutics. Philadelphia 1993 1-10
29. Des Jarlais D C., Diaz T, Perlis T et al. Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City. Am J Epidemiol 2003 157 5 467-471 (Pubitemid 36258602)
30. Hagan H, Des Jarlais D C., Stern R et al. HCV synthesis project: preliminary analyses of HCV prevalence in relation to age and duration of injection. Int J Drug Policy 2007 18 5 341-351 (Pubitemid 47374503)
31. Thorpe L E., Ouellet L, Hershow R, Bailey S, Williams I, Monerosso E. The multiperson use of non-syringe injection equipment and risk of hepatitis c infection in a cohort of young adult injection drug users, Chicago 19971999. Ann Epidemiol 2000 10 7 472-473
32. Thorpe L E., Ouellet L J., Hershow R et al. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am J Epidemiol 2002 155 7 645-653 (Pubitemid 34246097)
33. Burt R D., Hagan H, Garfein R S., Sabin K, Weinbaum C, Thiede H. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 1830 years, 19942004. J Urban Health 2007 84 3 436-454 (Pubitemid 46742831)
34. Hahn J A., Page-Shafer K, Lum P J. et al. Hepatitis C virus seroconversion among young injection drug users: relationships and risks. J Infect Dis 2002 186 11 1558-1564 (Pubitemid 35379631)
35. Kamili S, Krawczynski K, McCaustland K, Li X, Alter M J. Infectivity of hepatitis C virus in plasma after drying and storing at room temperature. Infect Control Hosp Epidemiol 2007 28 5 519-524 (Pubitemid 46814539)
36. Hagan H, Pouget E R., Des Jarlais D C. A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs. J Infect Dis 2011 204 1 74-83
37. Terrault N A. Sexual activity as a risk factor for hepatitis C. Hepatology 2002 36 5, Suppl 1 S99-S105 (Pubitemid 35253469)
38. Tohme R A., Holmberg S D. Is sexual contact a major mode of hepatitis C virus transmission? Hepatology 2010 52 4 1497-1505
39. Alter M J., Kruszon-Moran D, Nainan O V. et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999 341 8 556-562 (Pubitemid 29384163)
40. Hagan H, Snyder N, Hough E et al. Case-reporting of acute hepatitis B and C among injection drug users. J Urban Health 2002 79 4 579-585 (Pubitemid 36076531)
41. Robotin M C., Copland J, Tallis G et al. Surveillance for newly acquired hepatitis C in Australia. J Gastroenterol Hepatol 2004 19 3 283-288 (Pubitemid 38338737)
42. Spada E, Mele A, Ciccozzi M et al, SEIEVA collaborating group. Changing epidemiology of parenterally transmitted viral hepatitis: results from the hepatitis surveillance system in Italy. Dig Liver Dis 2001 33 9 778-784 (Pubitemid 34071469)
43. Alter M J., Hadler S C., Judson F N. et al. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. JAMA 1990 264 17 2231-2235 (Pubitemid 20382128)
44. Williams I T., Bell B P., Kuhnert W, Alter M J. Incidence and transmission patterns of acute hepatitis C in the United States, 19822006. Arch Intern Med 2011 171 3 242-248
45. Armstrong G L., Alter M J., McQuillan G M., Margolis H S. The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States. Hepatology 2000 31 3 777-782 (Pubitemid 30118650)
46. Aach R D., Szmuness W, Mosley J W. et al. Serum alanine aminotransferase of donors in relation to the risk of non-A, non-B hepatitis in recipients: the transfusion-transmitted viruses study. N Engl J Med 1981 304 17 989-994 (Pubitemid 11156605)
47. Alter H J., Holland P V. Indirect tests to detect the non-A, non-B hepatitis carrier state. Ann Intern Med 1984 101 6 859-861 (Pubitemid 15187381)
48. Donahue J G., Muäoz A, Ness P M. et al. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 1992 327 6 369-373
49. Busch M P., Glynn S A., Wright D J. et al, National Heart, Lung, Blood Institute Nucleic Acid Test Study Group*. Relative sensitivities of licensed nucleic acid amplification tests for detection of viremia in early human immunodeficiency virus and hepatitis C virus infection. Transfusion 2005 45 12 1853-1863 (Pubitemid 43971412)
50. Kleinman S H., Stramer S L., Brodsky J P., Caglioti S, Busch M P. Integration of nucleic acid amplification test results into hepatitis C virus supplemental serologic testing algorithms: implications for donor counseling and revision of existing algorithms. Transfusion 2006 46 5 695-702
51. Sharma U K., Stramer S L., Wright D J. et al, Retrovirus Epidemiology Donor Study. Impact of changes in viral marker screening assays. Transfusion 2003 43 2 202-214 (Pubitemid 36207300)
52. Zou S, Dorsey K A., Notari E P. et al. Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing. Transfusion 2010 50 7 1495-1504
53. Zou S, Notari E P. IV, Stramer S L., Wahab F, Musavi F, Dodd R Y., ARCNET Research Group. Patterns of age- and sex-specific prevalence of major blood-borne infections in United States blood donors, 1995 to 2002: American Red Cross blood donor study. Transfusion 2004 44 11 1640-1647 (Pubitemid 39431285)
54. Armstrong G L. Injection drug users in the United States, 1979-2002: an aging population. Arch Intern Med 2007 167 2 166-173 (Pubitemid 46148064)
55. Sun C A., Chen H C., Lu S N. et al. Persistent hyperendemicity of hepatitis C virus infection in Taiwan: the important role of iatrogenic risk factors. J Med Virol 2001 65 1 30-34
56. Okayama A, Stuver S O., Tabor E et al. Incident hepatitis C virus infection in a community-based population in Japan. J Viral Hepat 2002 9 1 43-51 (Pubitemid 36002486)
57. Fukuizumi K, Sata M, Suzuki H, Nakano H, Tanikawa K. Hepatitis C virus seroconversion rate in a hyperendemic area of HCV in Japan: a prospective study. Scand J Infect Dis 1997 29 4 345-347
58. Buffington J, Murray P J., Schlanger K et al. Low prevalence of hepatitis C virus antibody in men who have sex with men who do not inject drugs. Public Health Rep 2007 122 Suppl 2 63-67 (Pubitemid 47443834)
59. Urbanus A T., van de Laar T J., Stolte I G. et al. Hepatitis C virus infections among HIV-infected men who have sex with men: an expanding epidemic. AIDS 2009 23 12 F1-F7
60. Fierer D S., Factor S H., Uriel A J. et al, Centers for Disease Control and Prevention (CDC). Sexual transmission of hepatitis C virus among HIV-infected men who have sex with menNew York City, 2005-2010. MMWR Morb Mortal Wkly Rep 2011 60 28 945-950
61. van de Laar T J., Pybus O, Bruisten S et al. Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men. Gastroenterology 2009 136 5 1609-1617
62. van de Laar T J., Matthews G V., Prins M, Danta M. Acute hepatitis C in HIV-infected men who have sex with men: an emerging sexually transmitted infection. AIDS 2010 24 12 1799-1812
63. Taylor L E., Holubar M, Wu K et al. Incident hepatitis C virus infection among US HIV-infected men enrolled in clinical trials. Clin Infect Dis 2011 52 6 812-818
64. Spradling P R., Richardson J T., Buchacz K et al, HIV Outpatient Study Investigators. Trends in hepatitis C virus infection among patients in the HIV Outpatient Study, 1996-2007. J Acquir Immune Defic Syndr 2010 53 3 388-396
65. Alter M J. Prevention of spread of hepatitis C. Hepatology 2002 36 5, Suppl 1 S93-S98 (Pubitemid 35253468)
66. Hwang L Y., Kramer J R., Troisi C et al. Relationship of cosmetic procedures and drug use to hepatitis C and hepatitis B virus infections in a low-risk population. Hepatology 2006 44 2 341-351 (Pubitemid 44214873)
67. Arcari C M., Alter M J. Controversies in HCV transmission: from tattoos to barbershops. In: Negro F, ed. Hot Topics in Viral Hepatitis. FB Communications, Rome 2008 11 19-27
68. Santayana G. Life of Reason, Reason in Common Sense. New York: Scribner's; 1905: 284. Available at: http://iat.iupui.edu/santayana/content/ santayana-quotations Accessed October 5, 2011